Liu, Q.; Hou, L.; Zhao, Y.; Yang, H.; Mo, Z.; Yu, F. Comparative Efficacy & Safety of Buparlisib Plus Fulvestrant, Fulvestrant Plus Dalpiciclib, and Ribociclib Plus Letrozole for Postmenopausal, Hormone Receptor-Positive, and HER2-Negative Breast Cancer. Clinics 2023, 78, 100291. https://doi.org/10.1016/.